NYSE:ECCV • US2698098850
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 118.434M 33.80% | 139.072M 17.43% | 179.768M 29.26% | 205.58M 14.36% | 222.12M 8.05% | 258.27M 16.27% | |
| EBITDA YoY % growth | N/A | N/A | N/A | 26.064M | 147.54M 466.07% | N/A | |
| EBIT YoY % growth | 68.863M 54.13% | 88.134M 27.98% | 107.214M 21.65% | 123.62M 15.30% | 141.91M 14.80% | N/A | |
| Operating Margin | 58.14% | 63.37% | 59.64% | 60.13% | 63.89% | N/A | |
| EPS YoY % growth | N/A 15.64% | 1.36 -14.78% | 1.17 -13.97% | 0.97 -17.42% | 0.91 -6.18% | 0.96 5.85% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.21 -11.63% | 0.22 -19.57% | 0.23 4.44% | 0.23 -5.31% | 0.23 7.14% | 0.20 -6.98% | 0.20 -12.09% | 0.20 -11.11% | 0.20 -11.11% |
| Revenue Q2Q % growth | 51.852M 4.65% | 53.75M 2.69% | 55.038M 13.66% | 56.087M 7.83% | 58.634M 13.08% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 30.615M | 34.519M | 35.879M | 37.658M 71.96% | 39.489M 28.99% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 33.02M 21.42% | 34.862M 8.94% | 37.534M 34.05% | 37.961M 22.01% | 38.397M 16.28% | N/A | N/A | N/A | N/A |
All data in USD
10 analysts have analysed ECCV and the average price target is 35.64 USD. This implies a price increase of 50.7% is expected in the next year compared to the current price of 23.65.
EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) will report earnings on 2026-05-26.
The consensus EPS estimate for the next earnings of EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) is 0.21 USD and the consensus revenue estimate is 51.85M USD.
The consensus rating for EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.